Steven Farrugia
Chief Tech/Sci/R&D Officer at NANOSONICS LIMITED
Profile
Steven Farrugia is currently the Chief Technology Officer at Nanosonics Ltd.
He previously worked at ResMed Pty Ltd.
as the Vice President-Technology from 2008 to 2015.
Dr. Farrugia has an undergraduate and doctorate degree from The University of Sydney.
Steven Farrugia active positions
Companies | Position | Start |
---|---|---|
NANOSONICS LIMITED | Chief Tech/Sci/R&D Officer | 2018-01-31 |
Former positions of Steven Farrugia
Companies | Position | End |
---|---|---|
ResMed Pty Ltd.
ResMed Pty Ltd. Medical SpecialtiesHealth Technology Part of ResMed, Inc., ResMed Pty Ltd. is an Australian company that offers a range of insomnia treatments and snoring solutions. ResMed is based in Bella Vista, AU. Insomnia, defined as an inability to fall asleep or stay asleep, affects many people and can lead to symptoms of sleep deprivation. ResMed provides products to help individuals regain healthy sleep. The private company also offers solutions for snoring, including behavioral and lifestyle changes, anti-snoring devices, surgery, and CPAP therapy. | Chief Tech/Sci/R&D Officer | 2015-09-30 |
Training of Steven Farrugia
The University of Sydney | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NANOSONICS LIMITED | Health Technology |
Private companies | 1 |
---|---|
ResMed Pty Ltd.
ResMed Pty Ltd. Medical SpecialtiesHealth Technology Part of ResMed, Inc., ResMed Pty Ltd. is an Australian company that offers a range of insomnia treatments and snoring solutions. ResMed is based in Bella Vista, AU. Insomnia, defined as an inability to fall asleep or stay asleep, affects many people and can lead to symptoms of sleep deprivation. ResMed provides products to help individuals regain healthy sleep. The private company also offers solutions for snoring, including behavioral and lifestyle changes, anti-snoring devices, surgery, and CPAP therapy. | Health Technology |
- Stock Market
- Insiders
- Steven Farrugia